Freya: Restoring microbial balance in the reproductive tract
Shifting the inflammatory vaginal microbiome back to a healthy, Lactobacillus-dominant one
Freya is leveraging learnings from clinical trials of vaginal microbiome transplants to develop bacterial products that reduce local inflammation and support healthy pregnancies.
The company was born out of the gut microbiome boom. “In the last 10 years, there’s been quite a lot of progress in the gut microbiome space. Several of our co-founders wondered if we could apply that idea to the reproductive microbiome space,” Freya Biosciences ApS co-founder and CEO Colleen Acosta told BioCentury. Before Freya, Acosta was an epidemiologist at the WHO...